Alnylam Pharmaceuticals, Inc. portfolio

ALNYUnited States

Every trademark Alnylam Pharmaceuticals, Inc. holds, newest filings first. The portfolio has 69 marks filed under 10 owner names.

Company overviewGet this data via the API

Search this portfolio

Trademarks on file
69
Active
65
Owner names grouped
10
Portfolio

All trademarks

50 marks per page, newest filing date first. Pick an office to narrow the list.

MarkStatusOfficeClassesFiled
SIRELISmixedWIPO40, 422026-01-26
tm_aa87d6be-ad52-44f7-97df-f154c344cb28mixedWIPO52025-12-22
RNAISCIENCEmixedWIPO422024-08-05
OXALACTregisteredEUIPO42, 442024-07-04
OXALACTregisteredIPI42, 442024-07-04
RNAI REVOLUTIONmixedWIPO422024-07-03
DISRUPTING DISEASEmixedWIPO422024-07-03
RNAi RevolutionmixedWIPO422024-07-03
IKARIAfiledCIPO422024-06-21
GENEACTregisteredEUIPO42, 442024-06-20
GENEACTregisteredIPI42, 442024-06-20
ALNYLAM ACTregisteredCIPO422024-06-19
AlnylamAct & DesignregisteredCIPO422024-06-19
the BRIDGEregisteredWIPO35, 41, 442023-05-08
IKARIAmixedWIPO5, 422021-11-01
POWER OVER AHP Global Perspectives on living with Acute Hepatic PorphyriaregisteredWIPO35, 41, 442021-10-19
amvuttraregisteredWIPO52021-10-05
Gene Act ((fig.))registeredIPI42, 442021-04-26
AMVUTTRAmixedWIPO52020-09-04
OXLUMOregisteredWIPO52019-08-29
OXLUMO LogoregisteredCIPO52019-08-16
LUMZZIcancelledWIPO52019-03-29
OXLUMOmixedWIPO52019-03-29
LUMZZIregisteredCIPO52019-03-25
OXLUMOregisteredCIPO52019-03-25
GIVLAARI LogoregisteredCIPO52018-12-28
GIVLAARIregisteredWIPO52018-12-28
AMYLOCARE haTTR-Amyloidose Patientenservice ((fig.))registeredIPI44, 452018-10-05
[Design Mark]registeredIPOS52018-08-01
alnylamregisteredIPOS52018-08-01
201810039registeredNIPO52018-07-31
ALNYLAMregisteredNIPO52018-07-31
ALNYLAMregisteredIPI52018-07-25
FigurativeregisteredIPI52018-07-25
[Design Mark]registeredIP Australia52018-07-24
ALNYLAMregisteredIP Australia52018-07-24
alnylamregisteredIPOS422018-05-23
GIVLAARIregisteredWIPO52018-02-12
BREQUIOcancelledWIPO52018-02-12
BREQUIOregisteredCIPO52018-02-07
GIVLAARIregisteredCIPO52018-02-07
onpattroregisteredWIPO52017-08-22
Onpattro LogoregisteredCIPO52017-08-16
ONPATTROregisteredCIPO52016-07-29
FAMATTRYregisteredCIPO52016-07-29
ONPATTROregisteredWIPO52016-07-28
FAMATTRYcancelledWIPO52016-07-28
FigurativeregisteredIPI422010-03-25
201002477registeredNIPO422010-03-05
[Design Mark]registeredIPOS422010-03-04
API

Get this data via the API

Everything on this page comes from the Signa API. Pull Alnylam Pharmaceuticals, Inc.'s full portfolio into your own product.

  • GET/v1/entities/{id}/trademarks

    Every trademark in the portfolio, filterable by office and class

  • GET/v1/entities/{id}/analytics

    Portfolio totals, disputes and ownership changes

  • GET/v1/entities/{id}

    Company record, ticker, LEI and owner names

Get API keyView docs
GET /v1/entities/{id}/trademarks
ID=ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5
curl https://api.signa.so/v1/entities/$ID/trademarks \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "object": "list",
  "data": [
    {
      "id": "tm_ced84021-423e-4296-8109-29a1b1e9e3f6",
      "mark_text": "SIRELIS",
      "office_code": "WO",
      "status": {
        "stage": "mixed"
      },
      "filing_date": "2026-01-26"
    },
    {
      "id": "tm_aa87d6be-ad52-44f7-97df-f154c344cb28",
      "mark_text": null,
      "office_code": "WO",
      "status": {
        "stage": "mixed"
      },
      "filing_date": "2025-12-22"
    }
  ],
  "has_more": true
}